Hong‐Lei Ma

622 total citations
27 papers, 459 citations indexed

About

Hong‐Lei Ma is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Hong‐Lei Ma has authored 27 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 12 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Hong‐Lei Ma's work include Liver Disease Diagnosis and Treatment (23 papers), Liver Diseases and Immunity (10 papers) and Lipid metabolism and disorders (6 papers). Hong‐Lei Ma is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Liver Diseases and Immunity (10 papers) and Lipid metabolism and disorders (6 papers). Hong‐Lei Ma collaborates with scholars based in China, Italy and United Kingdom. Hong‐Lei Ma's co-authors include Ming‐Hua Zheng, Kenneth I. Zheng, Yong‐Ping Chen, Giovanni Targher, Christopher D. Byrne, Pei‐Wu Zhu, Xiaoyan Pan, Yujie Zhou, Rafael S. Rios and Jacob George and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal Of Nutrition and Metabolism.

In The Last Decade

Hong‐Lei Ma

27 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hong‐Lei Ma China	13	361	152	116	79	65	27	459
Θεόδωρος Ανδρουτσάκος Greece	10	239 0.7×	145 1.0×	123 1.1×	64 0.8×	46 0.7×	36	390
Mariam Ziayee United States	2	513 1.4×	356 2.3×	151 1.3×	70 0.9×	23 0.4×	3	635
Taeang Arai Japan	13	276 0.8×	201 1.3×	94 0.8×	49 0.6×	23 0.4×	45	413
Tsutomu Tamai Japan	14	269 0.7×	172 1.1×	94 0.8×	61 0.8×	18 0.3×	37	508
Hakan Akın Türkiye	11	347 1.0×	185 1.2×	119 1.0×	95 1.2×	19 0.3×	26	471
Pierre M. Gholam United States	8	376 1.0×	200 1.3×	177 1.5×	101 1.3×	15 0.2×	22	505
Ian Homer Y. Philippines	8	473 1.3×	407 2.7×	99 0.9×	79 1.0×	46 0.7×	13	605
Junfeng Zhang China	10	249 0.7×	79 0.5×	94 0.8×	38 0.5×	33 0.5×	25	425
Gupse Adalı Türkiye	8	244 0.7×	137 0.9×	50 0.4×	88 1.1×	35 0.5×	33	419
Gennaro Santorelli Italy	7	446 1.2×	110 0.7×	240 2.1×	50 0.6×	13 0.2×	11	540

Countries citing papers authored by Hong‐Lei Ma

Since Specialization

Citations

This map shows the geographic impact of Hong‐Lei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Lei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Lei Ma more than expected).

Fields of papers citing papers by Hong‐Lei Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Lei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Lei Ma. The network helps show where Hong‐Lei Ma may publish in the future.

Co-authorship network of co-authors of Hong‐Lei Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Lei Ma. A scholar is included among the top collaborators of Hong‐Lei Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Lei Ma. Hong‐Lei Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feng, Gong, Kenneth I. Zheng, Liang‐Jie Tang, et al.. (2022). Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?. PubMed. 1(1). 30–34. 4 indexed citations

Ma, Hong‐Lei, et al.. (2022). Association of Homocysteine and Insulin Resistance with Increased Risk of Mortality in a Nondiabetic Population: Third National Health and Nutrition Examination Survey. Metabolic Syndrome and Related Disorders. 20(5). 255–263. 2 indexed citations

Zhang, Huai, Rafael S. Rios, Yangyang Li, et al.. (2022). J-shaped relationship between serum zinc levels and the severity of hepatic necro-inflammation in patients with MAFLD. Nutrition Metabolism and Cardiovascular Diseases. 32(5). 1259–1265. 10 indexed citations

Ma, Hong‐Lei, et al.. (2022). Association between hyperhomocysteinaemia and the risk of all-cause and cause-specific mortality among adults in the USA. British Journal Of Nutrition. 129(6). 1046–1057. 2 indexed citations

Zhang, Huai, Kenneth I. Zheng, Pei‐Wu Zhu, et al.. (2022). Lower serum copper concentrations are associated with higher prevalence of nonalcoholic steatohepatitis: a matched case–control study. European Journal of Gastroenterology & Hepatology. 34(8). 838–843. 8 indexed citations

Sun, Qingfeng, Liang‐Jie Tang, Mingjie Wang, et al.. (2022). Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease. Frontiers in Medicine. 9. 864570–864570. 12 indexed citations

Ma, Hong‐Lei, Kenneth I. Zheng, Rafael S. Rios, et al.. (2021). Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis. The Turkish Journal of Gastroenterology. 32(9). 758–764. 1 indexed citations

Li, Gang, Rafael S. Rios, Xinxin Wang, et al.. (2021). Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease. British Journal Of Nutrition. 127(11). 1613–1620. 9 indexed citations

Liu, Wen‐Yue, Xiaofang Zhang, Liang‐Jie Tang, et al.. (2021). Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients. Clinical and Molecular Hepatology. 28(2). 183–195. 9 indexed citations

10.

Li, Gang, Liang‐Jie Tang, Pei‐Wu Zhu, et al.. (2021). PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 10(3). 439–448. 7 indexed citations

11.

Xu, Ke, Kenneth I. Zheng, Pei‐Wu Zhu, et al.. (2021). Interaction of SAMM50-rs738491 , PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis. Journal of Clinical and Translational Hepatology. 10(2). 219–229. 10 indexed citations

12.

Liu, Wen‐Yue, Mohammed Eslam, Kenneth I. Zheng, et al.. (2021). Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 10 indexed citations

13.

Tang, Liang‐Jie, Hong‐Lei Ma, Mohammed Eslam, et al.. (2021). Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD. Metabolism. 128. 154958–154958. 28 indexed citations

14.

Xu, Gang, Yumin Wang, Zongrui Li, et al.. (2021). Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis. Clinical and Molecular Hepatology. 27(2). 329–345. 16 indexed citations

15.

Zhou, Yujie, Kenneth I. Zheng, Hong‐Lei Ma, et al.. (2020). Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD. Nutrition Metabolism and Cardiovascular Diseases. 31(2). 552–560. 15 indexed citations

16.

Zheng, Kenneth I., Pei‐Wu Zhu, Yangyang Li, et al.. (2020). FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease. British Journal Of Nutrition. 126(6). 813–824. 13 indexed citations

17.

Zheng, Kenneth I., Pei‐Wu Zhu, Hong‐Lei Ma, et al.. (2020). Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD. Nutrition Metabolism and Cardiovascular Diseases. 30(10). 1820–1825. 14 indexed citations

18.

Liu, Wen‐Yue, Kenneth I. Zheng, Xiaoyan Pan, et al.. (2019). Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 35(6). 1057–1064. 24 indexed citations

19.

Ye, Fangzhou, Wen‐Yue Liu, Kenneth I. Zheng, et al.. (2019). Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology. 32(1). 80–86. 8 indexed citations

20.

Ma, Feiyan, et al.. (2017). Changes in Ocular Hemodynamics after Carotid Artery Angioplasty and Stenting (CAAS) in Patients with Different Severity of Ocular Ischemic Syndrome. Current Eye Research. 43(2). 266–272. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact